Trademark Search  /  LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

○ Dead · Cancelled

U.S. federal trademark · Serial No. 79025194 · Reg. No. 3206472

Mark
LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES
Status
Cancelled
Serial Number
79025194
Registration No.
3206472
Filing Date
March 7, 2006
Registration Date
February 6, 2007
Class(es)
Class 016, Class 042, Class 044

Owners

Novo Nordisk A/S
16 · DK
Novo Nordisk A/S
16 · DK
Novo Nordisk A/S
16 · DK

Goods & Services

Medical and scientific research, namely, conducting clinical trials and studies relating to pharmaceutical preparations for the treatment of diabetes-related diseases and disorders, and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of diabetes-related diseases and disorders

Providing medical information on the efficacy of pharmaceutical preparations for the treatment of diabetes-related diseases and disorders

Printed newsletters, journals and magazines related to medical studies and research regarding pharmaceutical preparations for the treatment of diabetes-related diseases and disorders

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.